Pfizer, Merck launch large new trials of oral COVID-19 drugs
Bio Pharma Dive
SEPTEMBER 1, 2021
Both companies are racing to prove their oral antivirals as treatments for COVID-19. Key clinical results could come later this year.
Sat.Aug 28, 2021 - Fri.Sep 03, 2021
363 
Codivir Shows Promising Effect Against COVID-19
Pharma Mirror
SEPTEMBER 2, 2021
TEL AVIV, ISRAEL / DE BILT, NETHERLANDS – Codivir, a short synthetic 16 amino-acid peptide, derived from the HIV-1 integrase, was originally discovered at the Hebrew University in Israel. Code Pharma discovered that the peptide had a direct antiviral effect against SARS-CoV-2, the novel Coronavirus causing COVID-19. In-vitro studies conducted at the British virology research laboratory Virology Research Services in London then demonstrated a potent antiviral activity against SARS-CoV-2 and
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Italian ‘chatbot’ predicted COVID-19 spikes, says study
pharmaphorum
SEPTEMBER 2, 2021
An online tool used by people in Italy to manage their potential exposure to COVID-19 using a simple chat interface has shown that it can spot emerging trends days ahead of the national surveillance system. The decision support system (DSS) – developed by Italian digital health startup Paginemediche – provided a way for people to assess and interpret their symptoms and provide guidance on what to do next, such as self-isolate or seek out a test.
New COVID-19 Variant C.1.2 Sparking International Concern
BioSpace
AUGUST 29, 2021
A new variant, C.1.2. is causing public health experts worldwide to keep an eye out for its presence as it seems to be more infectious and even more resistant to vaccines than other variants.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Top FDA vaccine officials to leave agency as decision on COVID-19 boosters looms
Bio Pharma Dive
AUGUST 31, 2021
Marion Gruber and Phil Krause, two veteran vaccine reviewers, are unexpectedly leaving the agency at a critical time. The search for their replacements will begin "imminently," division head Peter Marks said in a letter.
Revive Therapeutics reports progress with Phase III COVID-19 trial
Outsourcing Pharma
AUGUST 30, 2021
A leader from the rare and infectious disease treatment specialist talks about ongoing research into a potential treatment for mild-to-moderate COVID-19.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
GSK, SK to compare COVID-19 vaccine candidate to AZ’s jab
Pharma Times
AUGUST 31, 2021
Phase III trial will use AZ’s COVID-19 vaccine as an active comparator
At FDA meeting, gene therapy experts wrestle with field's blindspots
Bio Pharma Dive
SEPTEMBER 3, 2021
A panel convened by the regulator suggested ways to make gene therapy research safer, but struggled to propose broader recommendations for the field.
DoKaSch Temperature Solutions opens new service station in India
Pharma Mirror
SEPTEMBER 2, 2021
Frankfurt/Hyderabad, DoKaSch Temperature Solutions has opened a new service station in India. It is located at GMR Hyderabad Air Cargo terminal. Strategically, the Hyderabad Airport location is a very important network station for the global supply of lifesaving medicines given Hyderabad’s status as a major pharma production and export hub. With the new location in India, DoKaSch strengthens its network in the region and globally.
Temporarily understaffed in your clinical trials?
Deltaclinical
AUGUST 31, 2021
Are you temporarily understaffed in your clinical trials and in need for support? Contact us and we’ll come up with a solution that fits your needs! At Delta Healthcare Consulting we provide all kinds of staff solutions like: study nurses, laboratory technicians, project managers, data entry staff, clinical trial home nurses, … Contact us for the right solution!
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Roche withdraws US approval for Tecentriq in mTNBC
Pharma Times
AUGUST 31, 2021
Metastatic triple-negative breast cancer treatment failed to meet PFS primary endpoint
Moderna founder's next big play in RNA raises $440 million
Bio Pharma Dive
AUGUST 30, 2021
Just a few months out of stealth mode, Laronde and its "endless RNA" technology have caught the attention of well-known investors like Fidelity, T. Rowe Price Associates and Invus.
Online health seekers are having a tough time
World of DTC Marketing
AUGUST 31, 2021
SUMMARY: Online health seekers are increasing in number, but so is the prevalence of inaccurate health information. Drug side effects are among the most talked about in social media, and patients are more concerned about side effects. They may not be willing to risk potential side effects like pancreatitis. DTC marketers need to reassure their audiences that drugs have been thoroughly tested and are indeed “safe and effective.” Online health seekers are not having an easy time gettin
Temporarily understaffed in your clinical trials?
Deltaclinical
AUGUST 31, 2021
Are you temporarily understaffed in your clinical trials and in need for support? Contact us and we’ll come up with a solution that fits your needs! At Delta Healthcare Consulting we provide all kinds of staff solutions like: study nurses, laboratory technicians, project managers, data entry staff, clinical trial home nurses, …. Contact us for the right solution!
Novartis and the NHS sign ‘landmark’ deal for cholesterol drug
Pharma Times
SEPTEMBER 1, 2021
Treatment could help 300,000 patients over three years
What to expect at the FDA's two-day meeting on gene therapy safety
Bio Pharma Dive
SEPTEMBER 1, 2021
A group of advisers convened by the regulator will spend Thursday and Friday weighing a range of safety worries with gene therapy, and how best to prevent them.
Lumiio streamlines data collection, changing the face of global health collaboration
Pharma Mirror
AUGUST 30, 2021
CALGARY, AB: Reliable, consistent, and applicable data is a key feature of well-executed research and the development of new treatments. For some diseases and disorders, possible study participants are spread out across the world, preventing effective research and slowing down the process of improving quality of life for the people who need them most.Lumiio is determined to change this.
Temporarily understaffed in your clinical trials?
Deltaclinical
AUGUST 31, 2021
Are you temporarily understaffed in your clinical trials and in need for support? Contact us and we’ll come up with a solution that fits your needs! At Delta Healthcare Consulting we provide all kinds of staff solutions like: study nurses, laboratory technicians, project managers, data entry staff, clinical trial home nurses, …. Contact us for the right solution!
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
IQVIA launches AI-powered medical information contact centre
Pharma Times
SEPTEMBER 2, 2021
AI tech designed to improve patient and HCP experience
With safety worries mounting, FDA limits who can take certain immune-regulating drugs
Bio Pharma Dive
SEPTEMBER 1, 2021
The agency has new rules for who can take Pfizer's Xeljanz, Eli Lilly's Olumiant or AbbVie's Rinvoq after a large study raised concerns about the safety of so-called JAK inhibitors.
Azelis publishes its 2020 sustainability report
Pharma Mirror
AUGUST 28, 2021
SINGAPORE- Azelis, a leading innovative service provider in the specialty chemicals and food ingredients industry, is proud to publish its second sustainability report which covers the 2020 group-wide sustainability performance. Highlights & rationale– The report showcases Azelis’ environmental, social, and governance (ESG) commitments and reinforces its ambitions to become the world-leading provider of sustainable solutions and services– Azelis sustainability strategy, Act
Temporarily understaffed in your clinical trials?
Deltaclinical
AUGUST 31, 2021
Are you temporarily understaffed in your clinical trials and in need for support? Contact us and we’ll come up with a solution that fits your needs! At Delta Healthcare Consulting we provide all kinds of staff solutions like: study nurses, laboratory technicians, project managers, data entry staff, clinical trial home nurses, …. Contact us for the right solution!
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MHRA nod for AbbVie’s Rinvoq for adults and adolescents with eczema
Pharma Times
SEPTEMBER 1, 2021
Large-scale phase III study met all primary and secondary endpoints
Pfizer, marking fast research pace, starts key trial of RSV vaccine
Bio Pharma Dive
SEPTEMBER 2, 2021
The pharma company is in a tight race with rivals, including GSK, to become the first with an approved shot for the infectious disease.
Agilex Biolabs Partners with Endpoints News for Webinar on Rapid Vaccine Development in Australia
Pharma Mirror
AUGUST 28, 2021
ADELAIDE- Agilex Biolabs, the Australian specialist bioanalytical and toxicology laboratory facilities for clinical trials is partnering with Endpoints News to share the latest on “Non-clinical and clinical pathways for rapid vaccine development in Australia”, in a webinar hosted by Endpoints News Editor Arsalan Arif. Agilex Biolabs’ Director, Immunoassay, Kurt J.
Real-world study suggest AI may improve atrial fibrillation screening
pharmaphorum
SEPTEMBER 1, 2021
An artificial intelligence algorithm already shown to be able to detect atrial fibrillation (AF) in clinical testing has also shown its worth in a real-world setting, according to its developers. The AI – developed by the Bristol Myers Squibb-Pfizer Alliance on cardiovascular disease – was developed using machine learning from a UK dataset of almost 3 million patients and previously found to be more effective than existing testing at identifying patients at risk of AF based on retrospective stud
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Moderna submits its COVID-19 vaccine booster to the FDA
Pharma Times
SEPTEMBER 3, 2021
Trial showed ‘robust antibody responses’ against Delta variant
Settling lawsuit, AstraZeneca and European Commission agree on coronavirus vaccine delivery
Bio Pharma Dive
SEPTEMBER 3, 2021
The U.K.-based drugmaker fell behind on its promise to supply 300 million doses by the end of June to countries in the trading bloc. Now, it's set to reach that target by March 2022.
New collaboration to develop an inhalable SF2523 for lung cancer, lung fibrosis and SARS-CoV-2
Pharma Mirror
AUGUST 28, 2021
SignalRx Pharmaceuticals Inc., Crystec Ltd., and ADYA Consulting SAGL are pleased toannounce a new collaboration to develop an inhaled dry powder formulation of SF2523 for the treatmentof pulmonary fibrosis, lung cancer and SARS-CoV-2 related illnesses. SignalRx SF2523 is a novel, small molecule dual PI3K-BRD4 inhibitor with a synergistic action on twopathways associated with the development of lung cancer and idiopathic pulmonary fibrosis (IPF).
How the UAE is Growing Climate-Proof Food in the Desert
XTalks
AUGUST 30, 2021
Desert farming has existed for thousands of years , but one center in Dubai has created desert farming equipped to handle rising temperatures and extreme weather events. While these climate change-induced factors tend to make farming difficult and disrupt food distribution, Dubai’s International Center of Biosaline Agriculture (ICBA) is creating solutions to boost local food production in the driest and hottest conditions.
Let's personalize your content